miR-330-5p inhibits NLRP3 inflammasome-mediated myocardial ischaemia–reperfusion injury by targeting TIM3 Wei ZuoRan TianZhenyu Liu Original Article 02 November 2020 Pages: 691 - 705
Toward Better Reproducibility in Experimental Research on New Agents for Pulmonary Hypertension. An Analysis of Data from Four Hundred Animal Studies Magdalena Jasińska-Stroschein Original Article Open access 09 December 2020 Pages: 707 - 718
BKCa Channel Activation Attenuates the Pathophysiological Progression of Monocrotaline-Induced Pulmonary Arterial Hypertension in Wistar Rats Ana Paula FerrazFernando A. C. SearaJose Hamilton M. Nascimento Orignal Article 27 November 2020 Pages: 719 - 732
Chronic Naltrexone Therapy Is Associated with Improved Cardiac Function in Volume Overloaded Rats Lukas DeheMohammed ShaquraSascha Treskatsch Routine Article Open access 23 January 2021 Pages: 733 - 743
The Redox Modulating Sonlicromanol Active Metabolite KH176m and the Antioxidant MPG Protect Against Short-Duration Cardiac Ischemia-Reperfusion Injury Yang XiaoKaren YimCoert J. Zuurbier Original Article Open access 29 April 2021 Pages: 745 - 758
Effects of Angiotensin Receptor-Neprilysin Inhibitor in Arrhythmogenicity Following Left Atrial Appendage Closure in an Animal Model Wen-Han ChengIsaiah C. LugtuLi-Wei Lo Original Article 05 April 2021 Pages: 759 - 768
Ang II Promotes SUMO2/3 Modification of RhoGDI1 Through Aos1 and Uba2 Subunits, and then Regulates RhoGDI1 Stability and Cell Proliferation Yan QiHaijing GuanWenjuan Yao Short Communication 23 April 2021 Pages: 769 - 773
Cost-Effectiveness of Evolocumab Therapy for Myocardial Infarction: The Chinese Healthcare Perspective Zhe LiangQi ChenQuanming Zhao Original Article 22 October 2020 Pages: 775 - 785
Assessment of Low LDL Cholesterol in Patients Treated by PCSK9 Inhibition: Comparison of Martin/Hopkins and Friedewald Estimations Aya EgbariaWalid SalibaBarak Zafrir Short Communication 23 November 2020 Pages: 787 - 792
Association Between Omega-3 Fatty Acid Treatment and Atrial Fibrillation in Cardiovascular Outcome Trials: A Systematic Review and Meta-Analysis Xiaoming JiaFeng GaoChristie M. Ballantyne Original Article 31 May 2021 Pages: 793 - 800
Medical Treatment in Coronary Patients: Is there Still a Gender Gap? Results from European Society of Cardiology EUROASPIRE V Registry Pieter VynckierGiulia FerranniniOn behalf of the EUROASPIRE V Investigators group Original Article 17 October 2020 Pages: 801 - 808
Metformin Is Associated with Reduced Tissue Factor Procoagulant Activity in Patients with Poorly Controlled Diabetes Marco WitkowskiJulian FriebelUrsula Rauch Short Communication Open access 17 September 2020 Pages: 809 - 813
CD38: A Potential Therapeutic Target in Cardiovascular Disease Wanyun ZuoNa LiuQiming Liu Review Article 29 May 2020 Pages: 815 - 828
Cost-Effectiveness of Endovascular Versus Open Repair of Abdominal Aortic Aneurysm: A Systematic Review Shahin NargesiAli AbutorabiJavad Salimi Review Article 09 February 2021 Pages: 829 - 839
Bempedoic Acid in the Treatment of Patients with Dyslipidemias and Statin Intolerance Andrey V. SusekovLudmila A. KorolGerald F. Watts Review Article 27 January 2021 Pages: 841 - 852
Role of Bempedoic Acid in Clinical Practice Christie M. BallantyneHarold BaysJoseph J. Saseen Review Article Open access 05 April 2021 Pages: 853 - 864
Correction to: Role of Bempedoic Acid in Clinical Practice Christie M. BallantyneHarold BaysJoseph J. Saseen Correction Open access 19 April 2021 Pages: 865 - 865
Eliminating Gender Disparities in Coronary Heart Disease Treatment: Are We There Yet? Radmila LyubarovaGurleen KaurMandeep S. Sidhu Invited Editorial 18 November 2020 Pages: 867 - 869
Aspirin for Primary Cardiovascular Prevention in Patients with Family History of Cardiovascular Disease: Meta-analysis Miguel M. AntunesMariana AlvesDaniel Caldeira Letter to the Editor 16 October 2020 Pages: 871 - 873
Prediction of the Individual Risk of Bleeding in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention Patrick SulzgruberFelix HoferAlexander Niessner Letter to the Editor 04 March 2021 Pages: 875 - 876